Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose–response study of remazolam toluenesulfonic acid for induction of general anesthesia
ChiCTR2000039881Phase 4Recruiting
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in None (3 arms), sponsored by Zhejiang Provincial People's Hospital. Primary endpoints: Entropy index and Drug effect peak time T. Started Dec 2020; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2000039881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039881.